|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/08 | (2006.01) |
| A61K 31/517 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 4293024 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22752854.4 |
| Date of filing the European patent application | 2022-02-14 | |
| (97) | Date of publication of the European application | 2023-12-20 |
| (45) | Date of publication and mention of the grant of the patent | 2026-04-08 |
| (46) | Date of publication of the claims translation | 2026-05-25 |
| (86) | Number | PCT/JP2022/005582 |
| Date | 2022-02-14 |
| (87) | Number | WO 2022/173032 |
| Date | 2022-08-18 |
| (30) | Number | Date | Country code |
| 2021021656 | 2021-02-15 | JP |
| (72) |
YOSHINARI, Tomohiro , JP
ISHIOKA, Hiroki , JP
KAWAMINAMI, Eiji , JP
WATANABE, Hideyuki , JP
KAWAGUCHI, Kenichi , JP
KURAMOTO, Kazuyuki , JP
IMAIZUMI, Tomoyoshi , JP
MORIKAWA, Takahiro , JP
HAMAGUCHI, Hisao , JP
IMADA, Sunao , JP
OKUMURA, Mitsuaki , JP
NAGASHIMA, Takeyuki , JP
INAMURA, Kohei , JP
|
| (73) |
Astellas Pharma Inc. ,
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku
Tokyo 103-8411,
JP
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Chinazolino junginys, skirtas G12D mutantinio KRAS baltymo degradacijai sukelti |
| QUINAZOLINE COMPOUND FOR INDUCING DEGRADATION OF G12D MUTANT KRAS PROTEIN |